Pushing the boundaries of science to deliver life-changing medicines
Distinctive science supported by excellence in development and commercialisation are at the core of our commitment to deliver medicines that can transform the lives of patients around the world.
Our expertise spans the entire life-cycle of a medicine and we have a rare combination of discovery and development strengths in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare.
We work in over 100 countries, integrating our extensive therapy area knowledge with a deep understanding of the needs of patients and doctors, as well as healthcare providers, payers and regulators.
We know that innovation doesn’t happen in isolation, so we partner with others around the world, including academia, governments, industry and scientific organisations to access the best science and to contribute complementary technologies, know-how and molecules.
In our research laboratories, and those of our partners, our unrelenting focus is to stimulate scientific innovation and to accelerate the delivery of new life-changing
medicines that target unmet patient needs.
Our partnering approach is to tailor deals that are structured to drive real progress from bench to the bedside. From early-stage collaborations through to late-stage development and global commercialisation transactions, our aim is to create partnerships that are founded on trust and transparency, and that best achieve our mutual goals.